Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.4, 2005-01, pp. : 275-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

Potential of Substance P Antagonists as Antiemetics

By Diemunsch P.

Drugs, Vol. 60, Iss. 3, 2000-09 ,pp. : 533-546

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke: Scientific Rationale and Available Evidence

By Arthur M. Pancioli

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 981-988

Adis International

Access to resources Recommend Favorite

Adenosine A2A Receptor Antagonists for Parkinsons Disease: Rationale, Therapeutic Potential and Clinical Experience

By Hauser Robert A.

Drugs & Aging, Vol. 22, Iss. 6, 2005-01 ,pp. : 471-482

Adis International

Access to resources Recommend Favorite